Clinical Trial Update: A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Phase 3]

View source ↗

Summary

A Phase 3 trial in Indian postmenopausal women with osteoporosis completed and posted results evaluating the efficacy and safety of denosumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2013-12-25